{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:20:18Z","timestamp":1761898818297,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017951","name":"Health Commission of Qinghai Province","doi-asserted-by":"publisher","award":["2022-wjzdx-11"],"award-info":[{"award-number":["2022-wjzdx-11"]}],"id":[{"id":"10.13039\/100017951","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.clinre.2024.102302","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:55:27Z","timestamp":1707958527000},"page":"102302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Increased risk of colorectal adenomas with metabolic-associated fatty liver disease components"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9158-8011","authenticated-orcid":false,"given":"Dongsheng","family":"Ran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ChunLing","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingcai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2024.102302_bib0001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clinre.2024.102302_bib0002","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.clinre.2024.102302_bib0003","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2024.102302_bib0004","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/gutjnl-2021-324191","article-title":"Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2024.102302_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1068432","article-title":"Analysis of the correlation between non-alcoholic fatty liver disease and the risk of colorectal neoplasms","volume":"13","author":"Ye","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clinre.2024.102302_bib0006","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1200\/JCO.22.01740","article-title":"Increased risk of young-onset digestive tract cancers among young adults age 20-39 years with nonalcoholic fatty liver disease: a Nationwide Cohort Study","volume":"41","author":"Park","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinre.2024.102302_bib0007","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1756283X11402118","article-title":"Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease","volume":"4","author":"Touzin","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102302_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101401","article-title":"The risk of colorectal adenoma in nonalcoholic or metabolic-associated fatty liver disease","volume":"9","author":"Seo","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.clinre.2024.102302_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12154889","article-title":"Alteration of metabolic syndrome is associated with the decreased risk of colorectal cancer","volume":"12","author":"Jin","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinre.2024.102302_bib0010","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/codi.16092","article-title":"Systematic review and meta-analysis: associations between metabolic syndrome and colorectal neoplasia outcomes","volume":"24","author":"Lu","year":"2022","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.clinre.2024.102302_bib0011","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/jgh.16042","article-title":"The metabolic syndrome and its components as prognostic factors in colorectal cancer: a meta-analysis and systematic review","volume":"38","author":"Lu","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2024.102302_bib0012","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2024.102302_bib0013","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/apt.13866","article-title":"Non-alcoholic fatty liver diseases and risk of colorectal neoplasia","volume":"45","author":"Ahn","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2024.102302_bib0014","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s12072-022-10362-3","article-title":"A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population","volume":"16","author":"Zhang","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.clinre.2024.102302_bib0015","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: how is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.clinre.2024.102302_bib0016","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmet.2019.12.002","article-title":"Leveraging human genetics to identify potential new treatments for fatty liver disease","volume":"31","author":"Romeo","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.clinre.2024.102302_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10091877","article-title":"Performance of fatty liver index in identifying non-alcoholic fatty liver disease in population studies. A meta-analysis","volume":"10","author":"Castellana","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinre.2024.102302_bib0018","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MEG.0000000000002497","article-title":"Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD","volume":"35","author":"Chen","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2024.102302_bib0019","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1080\/07853890.2021.1956685","article-title":"Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)","volume":"53","author":"Cuthbertson","year":"2021","journal-title":"Ann Med"},{"key":"10.1016\/j.clinre.2024.102302_bib0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/DMSO.S189544","article-title":"The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011","volume":"12","author":"Khang","year":"2019","journal-title":"Diabet Metab Syndr Obes"},{"key":"10.1016\/j.clinre.2024.102302_bib0021","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s10620-021-06954-y","article-title":"Fatty liver index and development of cardiovascular disease: findings from the UK Biobank","volume":"66","author":"Zou","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2024.102302_bib0022","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/DCR.0000000000000973","article-title":"The fatty liver index: a simple and accurate predictor of colorectal adenoma in an average-risk population","volume":"61","author":"Ze","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clinre.2024.102302_bib0023","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102302_bib0024","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1440-1746.2009.06117.x","article-title":"Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps","volume":"25","author":"Hwang","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2024.102302_bib0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.14218\/JCTH.2019.00010","article-title":"Association between NAFLD and Risk of colorectal adenoma in Chinese Han Population","volume":"7","author":"Li","year":"2019","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.clinre.2024.102302_bib0026","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.gastro.2022.05.032","article-title":"Association between metabolic syndrome and the risk of colorectal cancer diagnosed before age 50 years according to tumor location","volume":"163","author":"Jin","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2024.102302_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101749","article-title":"Metabolic syndrome and colorectal adenoma risk: a systematic review and meta-analysis","volume":"45","author":"Wu","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102302_bib0028","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/1751-2980.12979","article-title":"Association of body fat distribution and metabolic syndrome with the occurrence of colorectal adenoma: a case-control study","volume":"22","author":"Liu","year":"2021","journal-title":"J Dig Dis"},{"key":"10.1016\/j.clinre.2024.102302_bib0029","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40292-020-00408-8","article-title":"Insulin resistance the hinge between hypertension and type 2 diabetes","volume":"27","author":"Mancusi","year":"2020","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.clinre.2024.102302_bib0030","doi-asserted-by":"crossref","first-page":"14700","DOI":"10.3390\/ijms140714700","article-title":"Enhanced development of azoxymethane-induced colonic preneoplastic lesions in hypertensive rats","volume":"14","author":"Kochi","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinre.2024.102302_bib0031","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2353\/ajpath.2006.051090","article-title":"The metabolic syndrome: a high-risk state for cancer?","volume":"169","author":"Cowey","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinre.2024.102302_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279242","article-title":"Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia","volume":"17","author":"Kim","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinre.2024.102302_bib0033","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.2021.4417","article-title":"Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force","volume":"325","author":"Lin","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.clinre.2024.102302_bib0034","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"Imperiale","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:36:32Z","timestamp":1761896192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740124000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2210740124000238"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102302","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased risk of colorectal adenomas with metabolic-associated fatty liver disease components","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102302"}}